Recipharm equips Lisbon facility for US and European serialisation
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.
The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016.
Recipharm has already delivered over 1.3 million serialised and aggregated packs to markets such as, China, South Korea, Saudi Arabia and Turkey where serialisation regulations are currently in place. The Lisbon site is the sixth to become serialisation-ready for the US and European markets and adds an additional four packaging lines to the company’s current serialisation capabilities. This will be followed by a further seven lines at the facility by Q2 in 2018.
Staffan Widengren, Director of Corporate Projects at Recipharm and head of the global steering committee for Recipharm’s serialisation project said: “Recipharm recognised the complexity of implementing serialisation at a very early stage and so we’ve been preparing for the new regulations in the US and Europe for a long time now. The Lisbon facility brings us to over a third of the way through our implementation project and is an important milestone in our journey.”
“We introduced our serialisation programme to ensure a consistent roll-out of our standard solution, without the implementation process having a significant impact on production activities. It’s important our solution works at a local level, as well as company-wide, and the central team that heads up the programme is tasked with making this happen.”
“Effective serialisation capabilities can eventually help companies to improve their overall equipment effectiveness (OEE) and streamline their operations. The programme also helps us to ensure that serialisation data integrates with our enterprise resource planning (ERP) activity and our manufacturing execution systems (MES) so that we can achieve wider business benefits beyond compliance.”
The central team is responsible for identifying, ordering, installing and qualifying serialisation systems in line with customer requirements. The next site to be equipped will be the company’s facility in Brescia, which will supply serialised product to the US.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Radical Attack on Live Cells - Stimulation of tiny areas on cellular surfaces with free radicals using a microfluidic probe
Bacteria in saliva can induce protective antibodies against SARS-CoV-2 - Important interaction between the oral microbiota and the immune system, especially in relation to vaccination
Blood discovery could benefit preemies, help end platelet shortages
How resistant cancer cells can be fought
AI in Cell Research: Moscot Reveals Cell Dynamics in Unprecedented Detail - A Turning Point in Medical Research
Hemp helps to heal - International research team clarifies mode of action of cannabinoids in inflammation
Transparency for clinical trials - Transparency of study results in a public dashboard
Harvard University licenses kidney engineering technology to newly launched startup - Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease
Can we promote healthy ageing of our cells? - The "firefighter" protein calls for the degradation of defective proteins
The deep slumber of a hospital pathogen - Why infections with Acinetobacter baumannii can flare up again and again
